Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Sotera Health Co shareholders approved Ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-05-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm For Against Abstain Broker Non-Votes 267,310,915 223,069 55,857 N/A
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Sotera Health Co shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-05-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Approval, on an Advisory Basis, of the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 257,678,396 6,586,053 51,797 3,273,595
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Sotera Health Co shareholders approved Election of all four Class III director nominees at the 2026-05-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Sotera Health Company (the “Company”) held its 2026 annual meeting of stockholders on May 21, 2026 (the “Annual Meeting”). At the Annual Meeting, the stockholders (1) elected all four director nominees as Class III directors to serve a three-year term until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified
View on SEC.gov